These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1320782)

  • 1. Second-generation anti-HCV tests and surrogate markers in volunteer blood donors.
    Des Roziers NB; Nasr O
    Transfusion; 1992 Jun; 32(5):492. PubMed ID: 1320782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 4. Is anti-HCV blood donor screening useful?
    Fiedler H
    Lancet; 1990 Nov; 336(8724):1193. PubMed ID: 1978051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
    Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
    Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 7. The correlations of surrogate markers with anti-hepatitis C virus and other disease markers.
    Myhre BA; Jiminez L; Shitabata P; Ukkestad TS
    Ann Clin Lab Sci; 1994; 24(1):76-83. PubMed ID: 7511879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibody to hepatitis C virus in a blood donor population.
    Richards C; Holland P; Kuramoto K; Douville C; Randell R
    Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society.
    Aguelles O; Janot C
    Arch Virol Suppl; 1992; 4():249-52. PubMed ID: 1450696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 11. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
    Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
    Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of anti-HCV reactivity and ALT level.
    Zissis G; Marissens D; Herremans S; de Bruyère M; Lissenko D; Bohy E; Luyasu V
    Acta Clin Belg; 1994; 49(5):251-2. PubMed ID: 7527609
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus.
    Takikawa T; Hayashi H; Nishimura N; Yano M; Isomura T; Sakamoto N
    J Gastroenterol; 1994 Oct; 29(5):593-7. PubMed ID: 8000507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of anti-HCV among voluntary blood donors in Taiwan.
    Tsai SJ; Chen CJ; Hsieh YS; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):61-70. PubMed ID: 1657546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
    Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
    Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anti-HCV antibody in blood donors in the Tokyo area.
    Watanabe J; Minegishi K; Mitsumori T; Ishifuji M; Oguchi T; Ueda M; Tokunaga E; Tanaka E; Kiyosawa K; Furuta S
    Vox Sang; 1990; 59(2):86-8. PubMed ID: 2173281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.